Scisparc to acquire automax

Tel aviv, israel, april 11, 2024 (globe newswire) -- scisparc ltd. (nasdaq: sprc) ("company" or "scisparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that it signed a merger agreement (the “agreement”) with automax motors ltd. (“automax”), a leading vehicle importer company in israel.
SPRC Ratings Summary
SPRC Quant Ranking